Research Study

A Long-Term Non-Interventional Postmarketing Study to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Principal Investigator 
Baljinder Salh

Overview

Body Locations and Systems 
Ulcerative Colitis
ClinicalTrials.gov# 
NCT01848561
Status 
Recruiting
Study Start/End 
Jan 29, 2015 to Jun 30, 2023
Locations 
Diamond Health Care Centre, Vancouver General Hospital
Name/Title 
Graciela Tanjuatco, Study Coordinator
Phone 
604-875-4111 ext.67873
Purpose of Study 

This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label.


 

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.